One of the key challenges in drug design is achieving high selectivity to target specific biological pathways without affecting others. Catalysis can enhance selectivity by enabling the precise formation of specific chemical bonds and functional groups within the drug molecule. This targeted approach reduces side effects and improves the therapeutic efficacy of the drug.
